Singapore
Boustead buys 60% of UroMedTech in $6m prostate cancer bet
Boustead buys 60% of UroMedTech in $6m prostate cancer bet
The $6m investment expands the group's healthcare portfolio.
1 day ago
Healthway Medical expands with Bridgepoint Health buy
It will add 16 clinics and lift annual patient capacity above 1.3 million visits.
2 days ago
Singapore's CGH cuts desflurane, slashes emissions
Desflurane usage fell to just 1.44 litres in 2025 from 242 litres in 2019.
2 days ago
Singapore’s AI tool analyses heart attack damage within one minute
Cardiovascular disease is the leading cause of death in Singapore.
Singapore develops world-first fluorescent nanosensor to track gut health
It delivers optical readouts within minutes.
Duke-NUS to build wastewater disease early warning system with $2.3m grant
It is a cost-effective approach to monitoring disease at the community level.
Parkway MediCentre taps AeviceMD for home asthma monitoring
The bottle cap-sized device tracks a child’s lung sounds continuously at night.
Singapore heart centre deploys photo-counting CT for complex cardiac cases
Cardiovascular disease accounts for nearly one in three deaths in the country.
IHH earnings edge higher in Q1 despite currency headwinds
Core revenue rose 16% on a constant currency basis.
IHH Healthcare core profit up 3% in 2025 as revenue hits $6.6b
Core revenue rose 18%.
SCRS and Medtronic Singapore sign MoU to boost colorectal surgery training
Focus includes minimally invasive and technology-assisted surgical techniques.
Agilent and Singapore’s NATi sign research partnership on oligonucleotide therapeutics
The work focuses on oligonucleotide therapeutics.
Singapore heart centre adopts new imaging tech to cut invasive diagnostics
It allowed clinicians to obtain clear images of coronary arteries with a single scan.
NHG Health, Singtel deploy 5G teleconsultation in Singapore clinics
About 40 sites move to dedicated SIM connectivity amidst remote consultations push.
IHH Healthcare clinches sustainable loan for antibiotic stewardship
The company is also aiming to strengthen the tracking of antibiotic follow-up reviews.
Singapore and China broaden drug oversight deal to cover gene therapies
It alters regulatory pathway structure for emerging medical technologies.
New SingHealth-Health ministry AI system to predict amputation risks early in diabetic patients
It aims to detect risks three to five years early.
Most Read
1. Healthway Medical expands with Bridgepoint Health buy 2. AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings 3. Boustead buys 60% of UroMedTech in $6m prostate cancer bet 4. China’s healthcare defies Hang Seng slump with 0.9% gain 5. How can healthcare providers make AI pay off?Resource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential